Aclacinomycin

DRUG3 trials

Sponsors

Chinese PLA General Hospital, Shanxi Bethune Hospital, The First Affiliated Hospital of Soochow University

Conditions

AMLMDSRelapsed or Refractory Acute Myeloid LeukemiaRelapsed/Refractory AML

Phase 1

Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML）

CompletedNCT01690507

Chinese PLA General HospitalAML, MDS

Start: 2012-11-30End: 2016-01-31Updated: 2016-02-25

Phase 3

Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia

RecruitingNCT05726110

Shanxi Bethune HospitalRelapsed or Refractory Acute Myeloid Leukemia

Start: 2023-01-29End: 2024-12-31Target: 50Updated: 2024-10-22

Unknown Phase

Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients

The First Affiliated Hospital of Soochow UniversityRelapsed/Refractory AML

Start: 2023-05-01End: 2024-06-30Target: 20Updated: 2023-05-06

Related Papers

Decitabine-based chemotherapy followed by haploidentical lymphocyte infusion improves the effectiveness in elderly patients with acute myeloid leukemia

Oncotarget2016-08-1016 citations